文献速递乳房整形与再造美容整形

乳房假体周围包膜挛缩的转录组模拟同种异体移植排斥:一项匹配病例对照研究

Transcriptome of Capsular Contracture around Breast Implants Mimics Allograft Rejection: A Matched Case-Control Study.
PubMed 文献 · Plast Reconstr Surg · 2024-12-24

本研究对50名女性51侧乳房假体包膜活检标本进行全转录组RNA测序,比较Baker III或IV级包膜挛缩与Baker I级健康对照(按假体品牌、表面、平面和破裂状态匹配)。发现1500个差异表达基因,包膜挛缩信号通路模拟同种异体移植排斥,涉及先天和适应性免疫系统激活,B细胞作用较既往认识更重要,纤维化相关基因表达改变。

要点

  • 包膜挛缩信号通路模拟同种异体移植排斥,涉及先天和适应性免疫系统激活。
  • 包膜挛缩与巨噬细胞、CD4+ T细胞、B细胞和浆细胞表达增加相关。
  • B细胞在包膜挛缩发展中作用较既往假设更重要,疾病机制类似同种异体移植排斥。

核心结论

  • 结果表明B细胞在包膜挛缩发展中作用较既往假设更重要,疾病机制类似同种异体移植排斥,提示包膜挛缩是乳房假体的一种免疫排斥形式。

研究设计与样本

  • 匹配病例对照研究,从乳房隆胸后接受假体置换的女性中收集乳房假体包膜活检标本,包膜挛缩组(Baker III或IV级)与健康对照组(Baker I级)等数纳入,按假体品牌、表面、平面和破裂状态匹配,采用全转录组RNA测序进行基因表达谱分析。
  • 分析50名女性51侧乳房的活检标本。

主要发现

  • 根据包膜挛缩状态,共发现1500个差异表达基因。
  • 包膜挛缩信号通路模拟同种异体移植排斥,先天免疫系统(如IL1A/B、CXCl9、TREML4、CR1)和适应性免疫系统(如CD80、IFN-γ)均激活。
  • 包膜挛缩与巨噬细胞、CD4+ T细胞、B细胞和浆细胞表达增加相关,多种免疫球蛋白基因(如IGHD、IGHE)上调。
  • 多种纤维化相关基因在包膜挛缩乳房中显著上调(如MMP1、MMP1、MMP12)或下调(TIMP4),原文此处MMP1重复出现。

临床怎么用

  • 本研究识别了与包膜挛缩相关的关键基因,提示新药候选(如MMP1抑制剂)以改善乳房假体手术结局。
  • 将同种异体移植排斥研究与包膜挛缩研究协同,可能带来新的治疗策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Capsular contracture is a frequent and severe complication following breast implant surgery. Although several theories on the pathophysiology exist, the exact molecular mechanisms remain unclear. This study aimed to identify the specific genes, signaling pathways, and immune cells associated with capsular contracture. METHODS: Breast implant capsule biopsy specimens were collected from women undergoing implant replacement after breast augmentation. Patients with capsular contracture (Baker III or IV) and healthy controls (Baker I) were included in equal numbers and matched on the basis of implant brand, surface, plane, and rupture status. Whole transcriptome RNA sequencing was used for gene expression profiling. RESULTS: The authors analyzed biopsy specimens from 51 breasts of 50 women, revealing 1500 differentially expressed genes based on capsular contracture status. The findings revealed that capsular contracture signaling pathways mimic allograft rejection, with activation of both the innate immune system (eg, IL1A/B , CXCl9 , TREML4 , CR1 ) and the adaptive immune system (eg, CD80 , IFN-γ ). Capsular contracture was associated with increased expression of macrophages, CD4+ T cells, B cells, and plasma cells, with upregulation of several immunoglobulin genes (eg, IGHD , IGHE ). Moreover, several fibrosis-related genes were significantly upregulated (eg, MMP1 , MMP1 , MMP12 ) or downregulated ( TIMP4 ) in breasts with capsular contracture. CONCLUSIONS: The results indicate that B cells play a more crucial role in the development of capsular contracture than previously assumed. The disease mechanism resembles allograft rejection, indicating that capsular contracture is a form of immunological rejection of the breast implant. CLINICAL RELEVANCE STATEMENT: This study identified key genes associated with capsular contracture, suggesting new drug candidates (eg, MMP1 inhibitors) to improve breast implant surgery outcomes. Synergizing research on allograft rejection and capsular contracture could also lead to new treatment strategies.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Larsen A, Fritz BG, Weltz TK, et al. Transcriptome of Capsular Contracture around Breast Implants Mimics Allograft Rejection: A Matched Case-Control Study. Plast Reconstr Surg. 2024. PMID: 39787571. doi:10.1097/PRS.0000000000011938

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。